Success Story: NIW Approved Despite an RFE for a Synthetic Organic Chemistry Expert with Our Guidance

Client’s Testimonial:

 

"From start to finish, my experience working with North American Immigration Law Group for my EB2/NIW petition was truly excellent. Throughout the entire process, every communication was clear, thoughtful, and I always felt that the team had my best interests in mind. Whenever I had questions or was confused about the nature of the documents I had to prepare, they always walked me through the process step-by-step. I would recommend anyone desiring to file an EB2/NIW application to look no further than North American Immigration Law Group. Thanks to their care and attention, my I-140 was approved even after receiving an RFE.”

 


 

On March 5th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Scientist in the Field of Synthetic Organic Chemistry (Approval Notice).

 


 

General Field: Synthetic Organic Chemistry

 

Position at the Time of Case Filing: Senior Scientist

 

Country of Origin: United Kingdom

 

State of Residence at the Time of Filing: New York

 

Approval Notice Date: March 5th, 2026

 

Processing Time: 20 months

 


 

Case Summary:

 

In this EB-2 NIW case, the client pursued approval based on a practical idea with an outsized impact: speeding up how small molecule drug candidates are designed and synthesized by using high-throughput experimentation and machine learning to identify the right reaction conditions faster. Although USCIS issued an RFE, the petition was approved after we clarified both the national importance of the endeavor and the client’s demonstrated ability to advance it.

 

What the Client Does
 

The client holds a Ph.D. in chemistry and chemical biology and works in a research role within the U.S. pharmaceutical ecosystem. The proposed endeavor is to leverage state-of-the-art high-throughput experimentation tools and machine learning algorithms to predict suitable reaction conditions, reducing time and cost barriers that often slow pharmaceutical development. We framed this as a scalable approach that can improve efficiency in medicinal chemistry workflows, where small improvements in synthesis speed and reliability can meaningfully affect downstream development timelines.

 

How We Demonstrated Significance
 

Because NIW cases are not decided on credentials alone, we organized the evidence around independent reliance and peer trust, not just productivity.

 

  • Publications: 3 peer-reviewed journal articles, including 2 that were first-authored or co-first-authored
  • Citations: 226 citations to the client’s published work
  • Peer review: at least 6 completed reviews, reflecting recognition as a trusted evaluator of others’ research
  • Competitive support: major research funding tied to nationally important priorities, including support from U.S. government science agencies

 

Letters of Recommendation
 

The petition included 4 letters of recommendation, incorporating independent perspectives, to corroborate the objective record and translate technical work into clear significance for a non-specialist adjudicator. One expert stated that:

 

“His research outcomes provide abundant benefits in fostering scientific innovation in the United States, which demonstrates the ongoing demand for his particular expertise.”

 

The Result
 

After responding to the RFE with a tighter presentation of national importance, independent reliance, and peer trust, USCIS approved the NIW petition. This outcome reflects a record built around practical impact in drug-development-enabling chemistry, supported by measurable influence and credible third-party recognition.